Zantac Cancer (Stomach, Colon, Bladder, Lung) Recall Lawsuit Attorneys (April 2020 Updates)

The organic compound, formerly used to make rocket fuel, is known to cause cancer in research animals. NDMA is described as a waste product of industrial processes including the making of industrial lubricants and pesticides. It is part of the N-nitrosamine family of potent carcinogens. The yellowish, odorless liquid is said to be present at supposedly safe micro levels in some food products—particularly cured meats—and water supplies, even beer. 

The toxic chemical has been found to damage the liver and other organs in humans. The U.S. Environmental Protection Agency (EPA) has concluded that NDMA is a “probable human carcinogen” that can increase a person’s risk of developing cancer. Although most of what is currently known about NDMA’s carcinogenic qualities come from animal-based studies, the World Health Organization has reported that several case-control studies and one cohort study of dietary intake of high does of NDMA in the human body showed results “supportive of the assumption that NDMA consumption is a probable carcinogen is positively associated with either gastric or colorectal cancer.” The main issue in current Zantac and ranitidine medicines cases centers around the contamination of NDMA into the products during a chemical reaction in the manufacturing process.

Yes, on April 1, 2020 the FDA issued a recall of the drug. While many Americans take ranitidine over-the-counter (OTC) for relief of heartburn and indigestion, prescription-strength ranitidine is sometimes used by physicians to treat and prevent ulcers in patients. Although the FDA initially reported that NDMA levels in the contaminated ranitidine were barely any higher than the supposedly safe amounts found in common foods, it later declared the levels to be “unacceptably high.” However, the agency is not currently recommending that patients stop taking ranitidine products immediately, but urging patients to speak to their doctors about alternative prescription and OTC medications for their conditions. Meanwhile, several drug makers including Novartis-owned Sandoz Inc., Apotex, and GlaxoSmithKline (the original developer of Zantac), announced they were voluntarily recalling or halting distribution of some batches of their generic ranitidine-containing products in the U.S. and other countries. It’s important to note that to date, brand-name Zantac (manufactured by Sanofi) was voluntarily recalled on October 18, 2019, as was the generic version, ranitidine. If you are concerned whether your particular brand of ranitidine is affected, links to information about the specific products that have been recalled by their manufacturers are provided in the “Resources” section at the end of this article.

The environmental contaminant NDMA has been known to cause serious, non-cancerous liver damage in humans and is used by cancer researchers to induce liver tumors in rodents. It is believed to be a risk factor for a range of human digestive system cancers including that of the stomach, colon, pancreas, and liver as well as bladder cancer. Stomach Cancer Cancer of the stomach (adenocarcinoma) is treatable when caught at an early stage. Recent tests show one of its precursors can be the condition known as GERD or acid reflux. It is also believed to be associated with obesity and smoking, as well as poor diet.

Symptoms of stomach cancer include:

• Fatigue
• Feeling bloated after eating
• Feeling full after eating small amounts of food
• Persistent heartburn
• Nausea or vomiting
• Stomach pain
• Weight loss

Medical treatment options for stomach cancer depend on the stage that the disease has progressed to, and include surgery (including removal of the stomach), radiation and chemotherapy.

Bladder cancer is fairly rare, accounting for just five percent of cancers diagnosed in the U.S. It is more likely to strike males over age 55 than females and is more common among Caucasians than other races. Risk factors are believed to include family history, smoking, chronic bladder inflammation/infections, and exposure to certain industrial chemicals, including high levels of NDMA (n-nitrosodimethylamine). Like stomach cancer, bladder cancer is also highly treatable, with a reported five-year survival rate of over 75 percent. However, if left untreated it can spread to vital organs including the lungs and liver via the lymph nodes. Early symptoms can mimic those of urinary tract infections and other ailments, and include:

• pain during urination
• frequent need to urinate
• difficulty urinating
• blood in the urine

Once the disease has progressed, symptoms can include:

• weight loss
• fatigue
• loss of appetite

Bladder cancer is treated through surgical removal of cancerous tissue and even all or part of the bladder (cystectomy), chemotherapy, and radiation. Other Cancers High levels of NDMA has also been linked to the following types of cancer:

• Esophageal
• Pancreatic
• Lymphoma
• Lung tumors
• Prostate (in men under 65)
• Leukemia
• Multiple myeloma

Yes, since the FDA announcement, individual lawsuits and class action claims have already begun to be filed around the U.S. against the makers of Zantac and related products, including Sanofi. The defendants are being sued by plaintiffs who took Zantac and other ranitidine products and either developed cancer or claim to be at risk for cancer. The plaintiffs claim the drugmakers should have known of the potential risk for NDMA contamination and advised the medical community of the danger, in light of certain research that predated the FDA warning. This research reportedly found that ranitidine can degrade into NDMA when combined with water during a chemical reaction. Whenever there is a flurry of new class action cases brought against specific defendants in different states, those early cases are often consolidated in a single state in what is known as a multi-district litigation (MDL), where they can all be heard in the same federal court before the same judge. This is different from a class action lawsuit, and is done for efficiency in the pretrial hearing and motion process. A motion to have Zantac lawsuits centralized in an MDL has been filed and is pending in the U.S. District Court for the District of New Jersey. The litigation is still in its early stages and there have been no settlements or verdicts related to Zantac injuries announced yet.

If you or a loved one has taken Zantac or ranitidine and developed stomach or bladder cancer, contact the Zantac recall attorneys at Rosenfeld Injury Lawyers LLC at (888) 424-5757 to schedule a free consultation to discuss whether you have a valid claim for compensation from the drug companies involved. The medication you are taking now could cause serious medical complications in the months or years ahead. You could be eligible to receive financial compensation for all medical expenses associated with the health condition that resulted from your Zantac consumption, ongoing tests, lost income for the time your illness left you unable to work, pain and suffering, loss of normal life and other tangible and intangible damages. Our law firm accepts all wrongful death lawsuits and defective drug injury claims through contingency fee agreements which postpone payment for our legal services until after we have successfully resolved your case. If we are unable to secure compensation on your behalf through a trial award or negotiated out-of-court settlement, you owe us nothing. Let our experienced team of product liability and class action attorneys go to work for you and your family to fully compensate you for your Zantac cancer.

Have There Been any Settlements of Zantac Cancer Lawsuits?

No. There are no settlements of pending Zantac cancer lawsuits. If you or a family member has a cancer diagnosis related to Zantac usage, you should consult with a Zantac attorney to discuss your legal rights and options. Many defective drug cases, such as Zantac, proceed through multidistrict litigation for several years before settlement negotiations are considered.

How Long do I Have to File a Lawsuit for Cancer Related to Zantac Use?

The time requirement to file a Zantac cancer lawsuit will be dependent on where you live and when you were diagnosed with cancer. Cases, such as Zantac lawsuits, are governed by a statute of limitations for filing a case. Failure to comply with the applicable statute of limitations will bar a financial recovery. If you have questions about the statute of limitations for your situation, contact a Zantac cancer attorney at Rosenfeld Injury Lawyers.

Get a Free Consultation Today to Discuss Your Zantac Case. Get Legal Help From Trusted Zantac Cancer Recall Attorneys

Rosenfeld Injury Lawyers LLC is committed to providing hands-on legal service for people who are dealing with cancer of the bladder, stomach or colon following Zantac and ranitidine use. All of our prescription medication defect cases are handled on a contingency fee basis, where we only receive a legal fee when there is a successful recovery for you.  We are headquartered in Chicago, Illinois and handle cases across the United States. This webpage is prepared and updated by attorney Jonathan Rosenfeld. Updated April 14, 2020. Rosenfeld Injury Lawyers LLC is also reviewing Valsartan cancer lawsuits, a blood pressure medication that has been recalled due to NDMA contamination and various cancers.

NDMA Contamination in Ranitidine Products

Table information taken from the U.S. Food & Drug Administration. That information also contains the lot numbers of the product tested. Content current as of November 1, 2019.